Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Goodwill: 2018-2025

Historic Goodwill for Ptc Therapeutics (PTCT) over the last 7 years, with Sep 2025 value amounting to $82.3 million.

  • Ptc Therapeutics' Goodwill changed negligibly% to $82.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $82.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Ptc Therapeutics' latest filing, its Goodwill stood at $82.3 million for Q3 2025, which was down 0.00% from $82.3 million recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Goodwill high stood at $82.3 million for Q1 2021, and its period low was $82.3 million during Q1 2021.
  • Its 3-year average for Goodwill is $82.3 million, with a median of $82.3 million in 2025.